Related by context. All words. (Click for frequent words.) 78 Orally Active 76 Prolongs Survival 76 Previously Treated 75 Meets Primary Endpoint 75 Novel Oral 74 Antitumor Activity 74 Pegylated 74 Anti Tumor Activity 74 Anti Tumor 74 Drug Candidate 74 Pooled Analysis 74 Well Tolerated 73 Immunomodulatory 73 Tyrosine Kinase Inhibitor 73 Protease Inhibitors 73 Recombinant Human 73 Peginterferon 72 Single Dose 72 Antiviral Activity 72 Chronic Hepatitis B 72 Disease Progression 72 Hsp# Inhibitor 72 Chronic Hepatitis C 72 Relapsed Refractory 72 Voreloxin 72 Immune Responses 72 Cytotoxic 72 Nilotinib 72 Improves Survival 72 Patients Treated With 72 Mg Uk 72 Lenalidomide 72 Phase 2b Clinical Trial 72 Monoclonal Antibody 72 Long Term Efficacy 72 Kinase Inhibitor 72 Preclinical Data 72 Attenuates 72 Treatment Naïve 72 Antiviral Therapy 71 Selective Inhibitor 71 Plus Ribavirin 71 Aurora Kinase 71 Oral Fingolimod 71 Infected Patients 71 Mouse Model 71 Hypercholesterolemia 71 Vitro Activity 71 Prophylactic Treatment 71 Dasatinib 71 Complicated Skin 71 Advanced Colorectal Cancer 71 Transdermal Patch 71 Cannabinoid 71 Anthracycline 71 Pharmacokinetics PK 71 Protease Inhibitor 71 Bosutinib 71 Naive Patients 71 Pharmacokinetic Study 71 Inhaled Corticosteroids 70 Receptor Antagonists 70 Is Well Tolerated 70 Clinical Trial Results 70 Humanized Anti 70 Somatostatin 70 Study Evaluating 70 Conjugate 70 Hypertensive Patients 70 Efficacious 70 Novel Therapeutic 70 Inhibits 70 Phase 2a Trial 70 Cyclooxygenase 2 70 Monotherapy 70 Polymerase Inhibitor 70 FDA Okays 70 Investigational Treatment 70 Treatment Experienced 70 Pharmacodynamics 70 Shows Efficacy 70 Subtype 70 Receptor Agonist 70 Novel Inhibitor 70 Potent Inhibitor 70 Peginterferon Alfa 2a 70 Initiate Clinical Trial 70 Antitumor 70 Soft Tissue Sarcoma 70 Newly Diagnosed Multiple Myeloma 70 Improves Outcomes 70 Receives Orphan Drug Designation 70 Renal Cell Carcinoma 70 Metastatic Prostate Cancer 70 Epratuzumab 70 Investigational Compound 70 Factor Receptor 70 Hormone Refractory Prostate Cancer 70 Phase 2b Trial 70 Fludarabine 70 Previously Untreated 70 Relapsing Remitting Multiple Sclerosis 70 Refractory Hodgkin Lymphoma 70 Antigen Specific 70 Combination Therapy 70 efavirenz EFV 70 Tipranavir 70 Prodrug 70 Trial Evaluating 70 Novel Compound 70 Antiangiogenic 70 Placebo Controlled Trial 70 Mimetics 70 Decitabine 70 Interferon Beta 70 Presents Preclinical Data 69 Clinical Outcome 69 Combination Treatment 69 Low Dose 69 Dendritic Cells 69 Chemoradiation 69 Cyclophosphamide 69 Liposomal 69 ACE Inhibitors 69 Advanced Renal Cell 69 Benign Prostatic Hyperplasia 69 ceftazidime 69 Treated Patients 69 Significantly Improved 69 Daptomycin 69 Interferon beta 1a 69 Pegylated Interferon 69 Elderly Patients 69 Patients Receiving 69 Modulates 69 Maribavir 69 Capecitabine 69 cetuximab Erbitux R 69 Randomized Phase 69 Submits NDA 69 JAK Inhibitor 69 Adjunctive Therapy 69 Completes Patient Enrollment 69 Vicriviroc 69 Advanced Melanoma 69 Preclinical Study 69 Present Preclinical Data 69 Erlotinib 69 Plasmid DNA 69 Unfractionated Heparin 69 Posaconazole 69 Bevacizumab 69 pan HDAC inhibitor 69 Demonstrates Significant 69 Aptamer 69 Drug Shows Promise 69 Epidermal Growth Factor Receptor 69 ergot derivatives 69 Adefovir 69 Vildagliptin 69 Controlled Trial 69 Virus Infection 69 Protease 69 Phase IIb Trial 69 Chemokine Receptor 69 Tumor Targeting 69 Allogeneic 69 Moxifloxacin 69 Fungal Infections 69 cytidine 69 Linezolid 69 Monoclonal 69 Adjuvant Treatment 69 Systemic Delivery 69 Small Molecule 69 HDAC Inhibitor 69 Bortezomib 69 CYP#A# CYP#D# 69 Kinase Inhibitors 69 Conjugated 69 Files IND 69 Cholesterol Lowering Drug 69 First Patient Dosed 69 Phase 2a Clinical Trial 69 nucleoside analog 69 Initiates Dosing 69 Rotavirus Vaccine 69 Aliskiren 69 Fondaparinux 68 Demonstrates Potential 68 semisynthetic 68 Fluconazole 68 Hepatitis B Virus 68 PEG IFN 68 ritonavir boosted 68 Initiates Clinical Trials 68 Improved Survival 68 Dose Escalation Study 68 Statistically Significant 68 Advanced Solid Tumors 68 Respiratory Virus 68 Mg Usa 68 Lanthanum Carbonate 68 Inhibitors 68 generation purine nucleoside 68 Tumor Necrosis Factor 68 Angiotensin Converting Enzyme 68 Phase IIb Clinical Trial 68 bevacizumab Avastin R 68 Kidney Function 68 Disease Modifying 68 AnaSpec Introduces 68 Cell Adhesion 68 Retinoic Acid 68 Tigecycline 68 Interferon Gamma 68 Significantly Improves 68 Rheumatoid Arthritis Drug 68 Myelodysplastic Syndrome MDS 68 Phase 2b Study 68 Initiates Clinical Trial 68 Tumor Growth 68 Fluvastatin 68 Viral Load 68 Chronic Lymphocytic Leukemia 68 Skeletal Muscle 68 Novel Mechanism 68 Demonstrated Significant 68 Demonstrates Positive 68 Sustained Release 68 selective antagonist 68 Shows Promise Against 68 Releasing Factor 68 Pegylated Liposomal Doxorubicin 68 Non Responders 68 Induces 68 Castration Resistant Prostate Cancer 68 Adenoviral 68 Vaccine Adjuvant 68 Cytotoxicity 68 Chronic Constipation 68 endothelin receptor 68 Appears Safe 68 Safinamide 68 Diabetic Foot Ulcer 68 Brain Metastases 68 Secretase 68 Double Blind Placebo 68 substrates inhibitors 68 Survival Benefit 68 Receptor Antagonist 68 HCV Protease Inhibitor 68 Azacitidine 68 IND Application 68 polymerase inhibitor 68 Fluticasone 68 Improve Survival 68 imipramine Tofranil 68 Diabetic Nephropathy 68 Metastatic Melanoma 68 Transdermal Delivery 68 Integrase Inhibitor 68 Androgen Receptor 68 Epoetin Alfa 68 Myeloid 68 Demonstrates Efficacy 68 Phase III Clinical Trial 68 GLP1 68 Chronic Myeloid Leukemia 68 TO AVOID PREGNANCY WHILE 68 Fulvestrant 68 Fluorouracil 68 Tezampanel 68 Oncolytic 68 Glatiramer Acetate 68 Oral Mucositis 68 Gastrointestinal Stromal Tumors 68 Signaling Pathway 68 glutamyl 68 NS#/#A protease 68 Novel Antibiotic 68 Therapeutic Vaccine 68 ® lenalidomide 68 5alpha reductase 68 Leukemias 68 Dehydrogenase 68 Clinical Trial Evaluating 68 Antifungal 67 Sapacitabine 67 Nucleotide 67 Neuroprotective Effects 67 humanized monoclonal 67 Drug Resistant 67 Adjuvant Chemotherapy 67 Granulocyte Colony Stimulating Factor 67 Saquinavir 67 Initiates Clinical 67 Oral Formulation 67 vapreotide acetate 67 Relapsing Multiple Sclerosis 67 Meta Analysis 67 Angiogenic 67 Pramlintide 67 Ziprasidone 67 Atypical Antipsychotic 67 Aflibercept 67 SPRYCEL ® 67 #mg/#mg 67 lamivudine 3TC 67 Isavuconazole 67 Severe Sepsis 67 Placebo Controlled Study 67 Tesamorelin 67 Fixed Dose 67 Methylnaltrexone 67 Phase IIa Clinical Trial 67 PRN FDA Approves 67 Progressive Multifocal Leukoencephalopathy 67 Cardiotoxicity 67 Shows Promising 67 Antithrombin 67 Achieves Primary Endpoint 67 Carbamazepine 67 Taxane 67 CYT# potent vascular disrupting 67 Protein Kinase 67 pharmacologically active isomer 67 Fracture Risk 67 Cytarabine 67 Treatment Naïve Patients 67 Albuferon TM 67 Resistant Hypertension 67 Leukotriene 67 IMiDs ® 67 Vaginal Gel 67 Protein Kinase C 67 Ecallantide 67 Investigational Agent 67 Lung Cancer Drug 67 GHRH 67 Monoclonal Antibodies 67 Trastuzumab 67 FDA Approvals 67 vinorelbine tartrate 67 LHRH 67 Mycophenolate Mofetil 67 Demonstrates Potent 67 II Clinical Trial 67 Adjuvant Therapy 67 Cutaneous T 67 Interferon Alpha 67 imatinib Gleevec ® 67 sodium glucose cotransporter 67 Clindamycin 67 Darunavir 67 Double Blind Randomized 67 selective modulator 67 HCV Genotype 67 Anticancer Agent 67 Zoloft sertraline 67 Human Monoclonal Antibody 67 Regimens 67 terfenadine 67 Diffuse Large B 67 Oligonucleotides 67 Lupus Drug 67 Pafuramidine 67 Epothilone 67 deoxy 67 Lamivudine 67 Immune Therapy 67 Treatment Resistant 67 prostanoid 67 Atypical Antipsychotics 67 JAK2 Inhibitor 67 Palonosetron 67 Presents Preclinical 67 Therapeutic Efficacy 67 Antipsychotic 67 Osteoporosis Treatment 67 Investigational Oral 67 Copegus ribavirin 67 Sipuleucel T 67 Enoxaparin 67 Nitazoxanide 67 Treatment Naive HIV 67 Replacement Therapy 67 Vidaza azacitidine 67 Polymorphisms 67 Danazol 67 Temsirolimus 67 Myelofibrosis 67 Reductase 67 Medoxomil 67 Orally administered 67 Metastatic Colorectal Cancer 67 Amino Acid 67 Interferon Alfa 67 abacavir sulfate lamivudine 67 Blinatumomab 67 Nebulized 67 diarrhea predominant irritable 67 Shows Statistically Significant 67 Paraplatin ® 67 reverse transcriptase inhibitors 67 Autologous Stem Cell Transplantation 67 Progenitor Cells 67 Oral Spray 67 PEGylated Fab fragment 67 Invasive Fungal Infections 67 Quantitation 67 Incretin 67 Treatment Naive Patients 67 Mutational 67 Overactive Bladder 67 Metastatic Pancreatic Cancer 67 Anticoagulant 67 abacavir Ziagen 67 Anticancer Activity 66 Synthetic Peptide 66 selective kinase inhibitor 66 Deforolimus 66 Efficacy Trial 66 Mouse Models 66 Anti Inflammatory 66 Relapsed Refractory Multiple Myeloma 66 Prostatic 66 Peginterferon Alfa 2b 66 selectively binds 66 Gene Mutation 66 Alfacell proprietary ribonuclease 66 Treating Chronic 66 Subtypes 66 Pivotal Study 66 Endometrial Cancer 66 Atripla combines 66 Interferon alfa 66 Myeloma Patients 66 Dose Response 66 Fewer Side Effects 66 Smooth Muscle 66 Immunotherapeutic 66 NS5B polymerase 66 Novel Anti Inflammatory 66 pharmacokinetic interactions 66 Analogs 66 Secondary Hyperparathyroidism 66 FDA Clears 66 liposomal formulation 66 Synthase 66 Lacosamide 66 Diabetic Neuropathy 66 denileukin diftitox 66 Patients Treated 66 Clinical Efficacy 66 FDA APPROVES 66 Phospholipase A2 66 Ibritumomab Tiuxetan 66 Tumor Cells 66 Pulmonary Arterial Hypertension 66 Cholinesterase Inhibitors 66 Zorbtive TM 66 dasatinib Sprycel 66 thalidomide Thalomid 66 Tumor Progression 66 Hepatitis C Virus 66 Controlled Study 66 Malignant Glioma 66 Hepatocytes 66 Initiate Phase 66 Cell Proliferation 66 Potent Antiviral Activity 66 Polymorphism 66 bexarotene 66 ABLYNX 66 Relapsed Multiple Myeloma 66 Genotypes 66 benzimidazole 66 Versus Placebo 66 Study Showed 66 Hepatitis C Patients 66 Hepatitis C Genotype 66 Non Inferiority 66 Acute Ischemic Stroke 66 Antiplatelet 66 Clemens Injections 66 developing Bicifadine serotonin 66 indinavir Crixivan 66 Hepatic Encephalopathy 66 Telaprevir VX 66 Glucocorticoid 66 Inhibitory 66 NMDA Receptor 66 Tiotropium 66 5 Fluorouracil 66 Significantly Reduces 66 Successfully Completes Phase 66 Oral Insulin 66 Randomized Double Blind Placebo 66 Combo Therapy 66 amprenavir 66 Lymphoid 66 Lamotrigine 66 Significantly Reduced 66 Upregulation 66 Preclinical Models 66 Multiple Ascending Dose 66 Interferons 66 Unresectable 66 Beta Blocker 66 Bone Metastases 66 Histone Deacetylase 66 Therapy Improves 66 Antibacterials 66 Allergic Rhinitis 66 Budesonide 66 Methylprednisolone 66 adefovir dipivoxil 66 Secretion 66 alfa 2a 66 Myelodysplastic Syndromes 66 Phase III Trials 66 Tolerability 66 von Willebrand Factor 66 Luteinizing Hormone Releasing Hormone 66 itraconazole Sporanox 66 erlotinib Tarceva ® 66 COPEGUS R 66 Chronic Sinusitis 66 Presents Positive 66 NICE Recommends 66 IFN α 66 Sulfonylurea 66 Metabolites 66 Receives Approvable Letter 66 Fc fusion protein 66 Viral Suppression 66 Anticancer Drugs 66 Cilostazol 66 Hyperlipidemia 66 Glufosfamide 66 Interferon gamma 66 Immunogenicity 66 Ozarelix 66 Ridaforolimus 66 tazobactam 66 demethylating agent 66 IgG1 66 Initiates Phase 66 Assay Kits 66 Tubulin 66 Atypical Hemolytic Uremic Syndrome 66 ribavirin RBV 66 meropenem 66 Advanced Prostate Cancer 66 nizatidine 66 Suicidality 66 Poorly Controlled 66 Lowers Risk 66 Lymphocyte 66 Neuroprotective 66 Immunosuppression 66 docetaxel Taxotere ® 66 Dose Escalation 66 Intravesical 66 unfractionated heparin UFH 66 Node Positive 66 Leucovorin 66 Proven Effective 66 Kahalalide F 66 Raltegravir 66 ara C 66 Telbivudine 66 Effectively Treats 66 HBeAg positive 66 Insulin Resistance 66 alefacept 66 beta 1a 66 Excretion 66 Neuroprotection 66 Newly Diagnosed 66 Glycosylation 66 Cancer Vaccines 66 Randomized Double Blind 66 Cancer Cells 66 Phase III Trial 66 Galantamine 66 Patients Suffering 65 Inflammatory Markers 65 Randomized Study 65 Completes Enrollment 65 Kidney Transplant Recipients 65 dopamine D2 65 Intracellular 65 RNAi Therapeutic 65 Parenteral Nutrition 65 Renal Impairment 65 Vidaza R 65 Relapsed 65 nilotinib Tasigna 65 Knee Osteoarthritis 65 Tocilizumab 65 HER2 Positive Breast Cancer 65 5HT 65 indinavir 65 Demonstrates Statistically Significant 65 Proteasome 65 R Saizen R 65 Slow Progression 65 Parathyroid Hormone 65 Antifungals 65 RezularTM 65 Peroxisome Proliferator Activated Receptor 65 Ixabepilone 65 Generic Versions 65 Polyethylene Glycol 65 Prostate Cancer Cells 65 Potency 65 Bisphosphonate 65 immunoglobulin G 65 Fibrinogen 65 Omacetaxine 65 Dendritic Cell 65 Melphalan 65 Highly Potent 65 Elvitegravir 65 vinca alkaloid 65 Prospective Randomized 65 anionic backbone 65 5 HT6 receptor 65 Insulin Glargine 65 Haemophilus b Conjugate 65 Anti VEGF 65 NRTI resistance 65 Randomized Double blind 65 Potent Anti 65 Vinorelbine 65 Extended Release 65 Vidaza ® 65 Hepatocellular Carcinoma 65 Small Molecule Inhibitors 65 CD# CD# 65 Heart Failure Patients 65 Commence Phase 65 Pivotal Phase III 65 Enzyme Replacement Therapy 65 Interferon alpha 2b 65 CYP#A# substrate 65 Enalapril 65 Sanofi Pasteur Fluzone 65 Prostaglandin 65 TNF Tumor Necrosis Factor 65 Sustiva efavirenz 65 topoisomerase II inhibitor 65 HCV RNA polymerase 65 sunitinib Sutent ® 65 Exacerbation 65 Recombinant Protein 65 Breast Cancer Cells 65 Carboplatin Paclitaxel 65 Transmembrane 65 J Am Coll 65 Pivotal Phase 65 Protein Synthesis 65 Estrogen Receptor 65 Lyophilized 65 Plaque Psoriasis 65 nucleotide analogs 65 myelofibrosis polycythemia vera 65 Adalimumab 65 highly selective endothelin 65 Beta Amyloid 65 Ultrasensitive 65 paroxetine sertraline 65 Tacrolimus 65 Beneficial Effects 65 Metastatic Renal Cell Carcinoma 65 Alkaline Phosphatase 65 Blood Pressure Drug 65 Paclitaxel Carboplatin 65 J Clin 65 orally administered inhibitor 65 interleukin IL -# 65 Dose Finding 65 Gene Linked 65 Romidepsin 65 Thiazolidinediones 65 Bazedoxifene 65 Valsartan 65 nortriptyline Pamelor 65 Hydrochloride Injection 65 PEGylated anti 65 somatostatin analogue 65 Inflammatory Arthritis 65 oral prodrug 65 administered concomitantly 65 Granted Orphan Drug 65 Genetic Variation 65 exendin 4 65 Medullary Thyroid Cancer 65 Nat Clin Pract 65 See CLINICAL PHARMACOLOGY 65 Platelet Derived Growth 65 Bucindolol 65 Migraine Treatment 65 Intracranial Aneurysms 65 Ropinirole 65 Anthrax Toxin 65 Drug Fails 65 Vaccine Candidate 65 pegylated interferons 65 busulfan 65 Showed Significant 65 Diabetic Patients 65 Cardiovascular Events 65 Prolongs Life 65 Androgen 65 PAM4 65 Pediatric Patients 65 prochlorperazine 65 Nicotine Vaccine 65 protein tyrosine phosphatase 1B 65 Salivary 65 soluble tumor necrosis 65 Xeloda ® 65 Intravascular 65 Teduglutide 65 Tyrosine Kinase Inhibitors 65 Investigational Drug 65 Proc Am Soc 65 Initiates Phase II 65 Multiple Myeloma MM 65 Osteoporosis Drug 65 non nucleoside inhibitor 65 Glycoprotein 65 Contrast Agents 65 Subunit 65 Analogues 65 intranasal formulation 65 lanreotide 65 Therapeutic Vaccines 65 Hematopoietic 65 Immunoglobulin 65 Chimeric 65 Data Suggest 65 covalently bound 65 dasatinib Sprycel ® 65 Pemetrexed 65 Chemotherapy Induced 65 Anti TNF 65 Muscarinic 65 sulfonamide 65 Randomised 65 topical gel formulation 65 Pharmacologic 65 Tumor Response 65 Patients Undergoing 65 nucleoside analogues 65 Lupus Nephritis 65 FUSILEV enhances 65 Anticancer Drug 65 Prostate Cancer Vaccine 65 induce orthostatic hypotension 65 Pharmacokinetics 65 Epoetin 65 Cyclosporine 65 anti CD3 65 Histone 65 Benazepril 65 NDA Submission 65 Low Density Lipoprotein Cholesterol 65 Gleevec resistant 65 Gout Drug 65 unconjugated 65 Hormone Receptor Positive 65 Pralatrexate 65 uricase 65 Tumor Cell 65 Seasonal Allergic Rhinitis 65 Predict Response 65 Commences Phase 65 SAR# [002] 65 neuronal nicotinic receptor NNR 65 Angiotensin 65 Pertuzumab 65 tenofovir Viread 65 Superoxide 65 Erectile Dysfunction Drug 65 Sevelamer 65 Bronchodilator 65 Degarelix 65 Commonly Used 65 PEG Interferon 65 Seasonal Influenza Vaccine 65 Immunogenic 65 Psoriasis Drug 65 Rheumatoid Arthritis Patients 65 Int J 65 antiepileptics 65 Nucleic Acid 65 Entry Inhibitor 65 Locked Nucleic Acid LNA 65 Darusentan 65 Oral Anticoagulant 65 Gene Variation 65 metaglidasen 65 aspirin clopidogrel 65 Treatment Reduces 65 Stent Restenosis 65 T#I [002] 64 Treatment Naive 64 refractory chronic lymphocytic 64 N methyl 64 PKC# 64 Phase IIa Trial 64 HER1 64 Tegretol carbamazepine 64 Treatment Regimen 64 pegylated interferon alfa 2a 64 FEMALES SHOULD BE ADVISED 64 Darbepoetin Alfa 64 Confirmatory Phase 64 Bioavailability 64 Eculizumab 64 Benzyl 64 Bivalirudin 64 receptor modulators 64 siRNA binds 64 Statin Therapy 64 Blood Pressure Lowering 64 iobenguane 64 Janus kinase 64 Crit Rev 64 Thiovir 64 novel emulsion formulation 64 Protelos R 64 Bacteremia 64 reverse transcriptase inhibitor 64 pegylated 64 Earns Milestone Payment 64 Immunostimulatory 64 Prospective Randomized Trial 64 Fibroblast 64 demonstrated antitumor activity 64 C Reactive Protein 64 Begins Dosing 64 vesicular monoamine transporter 64 Elagolix 64 BARACLUDE R 64 Cocaine Addiction 64 Reduces Pain 64 tenofovir TDF 64 Enlarged Prostate 64 Phospholipase 64 phenothiazines 64 Critically Ill Patients 64 Kinoid 64 tumor xenograft models 64 Adjunctive 64 Antigenics QS 64 Mantle Cell Lymphoma 64 HCV Infection 64 heparanase 64 polyglutamate 64 AAG geldanamycin analog 64 Cancer Res 64 K ras mutations 64 Kuvan sapropterin dihydrochloride 64 Lung Cancer Survival 64 Phase III Clinical Trials 64 Nephrol 64 Postmenopausal Osteoporosis 64 Palifosfamide 64 lamotrigine Lamictal 64 Osteoporosis Drugs 64 Neurotransmitter 64 GW# [003] 64 selective agonist 64 fosbretabulin 64 prescribed proton pump 64 selectively inhibits 64 Topotecan 64 Develop Novel 64 Diuretic 64 AZT zidovudine Retrovir 64 5 FU leucovorin 64 Am J Clin 64 Breast Cancer Recurrence 64 cidofovir 64 Attenuated 64 Receives Orphan Drug 64 Breast Tumors 64 metastatic malignant 64 Circulating Tumor Cells 64 Sirolimus Eluting Stent 64 evaluating tivozanib 64 Agonist 64 Epilepsy Drug 64 cyclin dependent kinase inhibitor 64 immunotoxin 64 reuptake inhibitor 64 Study Demonstrates 64 Bare Metal Stents 64 Inhalation Solution 64 histone deacetylase HDAC inhibitor 64 Inflammatory Pain 64 Randomized Phase II 64 Biosynthesis 64 Doripenem 64 Ventricular Arrhythmias 64 Bosentan 64 adalimumab Humira 64 antiapoptotic 64 Gefitinib 64 HMG CoA reductase inhibitors 64 Darinaparsin 64 ADP receptor antagonist 64 Labeling Kit 64 Lung Cancer Patients 64 Inactivated 64 Ligands 64 Hepatitis B Vaccine 64 5 HT2A inverse 64 Teva Provides Update 64 Cathepsin S 64 receptor blocker 64 Oxidase 64 T Lymphocyte 64 Proteases 64 gemcitabine Gemzar 64 Ribavirin 64 2 methoxyestradiol 64 interferon IFN 64 Lubiprostone 64 R lenalidomide 64 Aptivus ® 64 Extracellular 64 interferon alfa 2b 64 lovastatin Mevacor 64 dual endothelin receptor antagonist 64 procainamide 64 Monopril 64 Modulating 64 alkylating 64 Genetic Variant 64 alpha 2a 64 Venlafaxine 64 Liver Failure 64 Acellular 64 Antiarrhythmic 64 Maleate 64 Hematological Cancers 64 Leukemia Cells 64 Leukocyte 64 Atopic Dermatitis 64 Non Invasive Treatment 64 thienopyridines 64 class anticancer quinolone 64 Partial Onset Seizures 64 Effective Than 64 Thromboembolism 64 Antibody Drug Conjugate 64 Avanafil 64 Protein Interactions 64 Uric Acid 64 Myocardial Perfusion Imaging 64 Transfection 64 Camptosar ® 64 Anti Inflammatory Drug 64 Pharmacodynamic 64 Peritoneal 64 Generic Version 64 Cardiac Troponin 64 beta interferons 64 clotrimazole 64 Adenoscan R 64 Analgesic 64 calcitonin gene related 64 Squalamine 64 Amikacin 64 Hospital Acquired Pneumonia 64 Androgen Deprivation Therapy 64 JAK2 V#F 64 Tocopherol 64 multitargeted 64 Beta Blockers 64 Commercially Available 64 Genes Linked 64 Blind Placebo Controlled Trial 64 Contrast Agent 64 Cardiac Function 64 Protein Kinase Inhibitors 64 Gonal f R 64 relapsed MM 64 protease inhibitor PI 64 polymyxin B 64 Polymerase 64 Lowers Cholesterol 64 Milestone Payment